LEES PHARMACEUTICAL Aktie

>LEE'S PHARMA Performance

1 Woche: -5,3%

1 Monat: -20,5%

3 Monate: -21,5%

6 Monate: -47,5%

1 Jahr: -24,4%

laufendes Jahr: -21,5%

>LEES PHARMACEUTICAL Aktie

Name:

LEE'S PHARMACEUTICAL HLDGS

Land:

China

Sektor:

Gesundheit

ISIN/ Wkn:

KYG5438W1116 / A12CU5

Symbol/ Ticker:

L1PA (Frankfurt)

Kürzel:

FRA:L1PA, ETR:L1PA, L1PA:GR

Index:

Webseite:

https://www.leespharm.com..

Profil:

Lee's Pharmaceutical Holdings Ltd. is a leading pharmaceutical company engaged in the research, development, manufacture, and distribution of medical products. Specializing primarily in cardiovascular, dermatology, and pediatrics, Lee's Pharmaceutica..
>Volltext..

Marktkapitalisierung:

80.68 Mio. EUR

Unternehmenswert:

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

0.01 EUR

Dividendenrendite:

3.56%

Dividendenschätzung:

3.98%

Div. Historie:

12.09.25 - 0.00242968€
28.05.25 - 0.002761€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

LEES PHARMACEUTICAL, LEE'S PHARMACEUTICAL, LEE S PHARMACEUTICAL, LEE'S PHARMA, LEE S PHARMA

Letzte Datenerhebung:

05.04.26

>LEE'S PHARMA Kennzahlen

Aktien/ Unternehmen:

Aktien: 588.84 Mio. St.

Frei handelbar: 54.38%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 1022

Umsatz/Mitarb.: 0.15 Mio. EUR

Analysten:

Analystenrating: No rating

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>LEE'S PHARMA Peer Group

Gesundheit

>LEE'S PHARMA Chart & Kurs - Stuttgart

>LEE'S PHARMA News

30.03.26 - 11:30	Results: LEE'S PHARMACEUTICAL Last Year's Net Profit Down 1.2% to HKD91.94 Million; Final Dividend of HKD0.023 (AAStocks)
	LEE'S PHARMACEUTICAL (00950.HK) announced its full-year results for the year ended last December, with revenue of HKD1.436 billion, up 2.6% YoY. Net profit was HKD91.938 million, down 1.2% YoY; EPS was HKD0.1561. A final dividend of HKD0.023 was declared, compared to HKD0.025 in the same period last year. (sl/w)~AASTOCKS Financi......

25.03.26 - 18:45	LEE'S PHARMACEUTICAL YINROSA Approved by National Medical Products Administration (AAStocks)
	LEE'S PHARMACEUTICAL (00950.HK) announced that the National Medical Products Administration of China has approved Yinrosa for the treatment of postmenopausal women with moderate to severe symptoms of vulvovaginal atrophy (excluding urinary tract symptoms). Yinrosa is owned by Cosette Pharmaceuticals and has been licensed to LEE'......

11.12.25 - 08:03	Lee′s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights (PR Newswire)
	Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products pipeline, and Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global......

09.12.25 - 14:06	Lee′s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights (PR Newswire)
	Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products pipeline, and Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global......

11.09.25 - 23:48	XFRA: DIVIDEND/INTEREST INFORMATION - 12.09.2025 - KYG5438W1116 (XETRA)
	Das Instrument L1PA KYG5438W1116 LEE S PHARMACEUTIC.HD-,05 EQUITY wird ex Dividende/Zinsen gehandelt am 12.09.2025 The instrument L1PA KYG5438W1116 LEE S PHARMACEUTIC.HD-,05 EQUITY has its ex-dividend/interest day on 12.09.2025...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram